Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Appointments

Request an Appointment

Cancer Answer Line:
866.223.8100

M-F 8 a.m. - 4:30 p.m. ET

Expand Content

View Cancer Clinical Trials

CASE 1A07   |   CC639
A Study of Outcomes and Toxicity of Busulfex as Part of a High Dose Chemotherapy Preparative Regimen in Autologous Hematopoietic Stem Cell Transplantation for Patients with Plasma Cell Myeloma

Disease(s)
Blood & Marrow Transplant (BMT)
Multiple Myeloma
Hospital(s)
Main Campus
Phase(s)
Stage(s)
Type(s)
Therapeutic
Drug(s)
Busulfex

Contact Information
Cancer Answer Line

866.223.8100

8:00 am - 4:30 pm, Monday - Friday


Description
  1. Primary Objective:
    • To compare relapse-free survival and overall survival between Busulfex and oral Busulfan when used for conditioning with cyclophosphamide in plasma cell myeloma patients undergoing autologous HSCT.
  2. Secondary Objectives:
    • To compare pulmonary toxicity rates between Busulfex and oral Busulfan when used for conditioning with cyclophosphamide in plasma cell myeloma patients undergoing autologous HSCT.

Inclusion Criteria
  1. Patients with a diagnosis of plasma cell myeloma
  2. Patients with cardiac ejection fraction ≥ 45% or clearance by CCF cardiologist
  3. Patients with DLCO ≥ 45% predicted or clearance by CCF pulmonologist
  4. Patient with previously harvested peripheral blood progenitor cells with a minimum of 2 x 10^6 CD34+ cells/kg harvested
  5. Patient is greater than 18 years of age

Exclusion Criteria
  1. Patients receiving total body irradiation
  2. Non-myeloablative/reduced-intensity conditioning
  3. Pregnant or breast-feeding patients
  4. HIV positive
  5. Patient with Serum creatinine > 2.0
  6. Prior HSC transplant

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).

Referrals

Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.